Carregando… / Loading…
Investigators and scientific partners
A real partnership, not a service contract. GIYUS comes in as a shareholder alongside the founding investigator and takes on everything that is not science.
Guaranteed by contract. Study selection, scientific conduct and clinical decisions remain entirely with the investigator.
Regulatory, contracts, budgeting, billing, quality, HR and technology become the hub's responsibility. Everything that isn't science leaves your desk.
The network's business development brings your site to sponsors and CROs an independent site rarely reaches.
You remain a shareholder of your own site and also share in the value of a consolidating platform, not just one unit's results.
Your site's name and history in CRO databases are assets we buy, not obstacles. The brand transition happens in three phases, conditioned on commercial evidence and always with the scientific partner consulted.
Phase 1 — Endorsement
Site X — a GIYUS company
Fully preserves the track record in CRO databases. It runs from acquisition until full integration into the platform: SOPs, systems and QA.
Phase 2 — Co-dominance
GIYUS | Site X
Begins once the site's metrics match the network standard and sponsors re-select it under that standard. The network brand starts adding measurable commercial value.
Phase 3 — Absorption
GIYUS Research Center | location
When the network brand is worth more than the local brand to CROs and sponsors. The calendar is a target; the triggers are law.
Every conversation starts confidential and with no commitment. Tell us a bit about your site.